Association Between Serum Neuregulin 4 and the Risk of Gestational Diabetes Mellitus: A 1:1 Matched Case–control Study

Lingling Cui,Zhiqian Li,Tingting Chen,Zhonglei Li,Yingying Guo,Jiaxin Li,Xiaoli Yang,Li Zhang,Xintong Li,Linlin Hua,Dongmei Xu,Xinxin Liu
DOI: https://doi.org/10.1007/s13410-024-01420-7
2024-01-01
International Journal of Diabetes in Developing Countries
Abstract:Neuregulin 4 (NRG4) , which belongs to the neuregulin growth factor family, is secreted from brown adipose tissue and now is extensively identified as a novel adipokine that improves insulin sensitivity. The purpose of the study was to investigate the possible association between serum NRG4 levels and GDM risk in Chinese pregnant women. A 1:1 matched case–control study was conducted in Chinese pregnant women between July 2018 and July 2019, involving 87 GDM cases and 87 controls. For all participants, anthropometric parameters and biochemical parameters were measured. Multivariate conditional logistic regression was used to analyze the relationship between serum NRG4 level and GDM risk. The serum NRG4 level was negatively correlated with 1 h plasma glucose, 2 h plasma glucose, and HOMA-IR (r = − 0.304, p < 0.001; r = − 0.273, p < 0.001; r = − 0.161, p = 0.034, respectively). The fully adjusted multivariate conditional logistic regression analysis showed that odds ratios (ORs) and 95
What problem does this paper attempt to address?